Qual é o preço para VistaGen Therapeutics, Inc. (VTGN)

O preço para VistaGen Therapeutics, Inc. (VTGN) é $0.2619

Qual é a capitalização de mercado para VistaGen Therapeutics, Inc. (VTGN)

A capitalização de mercado para VistaGen Therapeutics, Inc. (VTGN) é $11.62M

VistaGen Therapeutics, Inc. (VTGN) Preço e Capitalização de Mercado

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS). A key component of its CNS pipeline is PH94B, a fast-acting neuroactive nasal spray currently in Phase III trials for the rapid treatment of anxiety in adults experiencing social anxiety disorder. PH94B also shows potential for addressing a broader spectrum of anxiety conditions, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder (PTSD), pre-procedural anxiety, and panic disorders. The company's CNS development initiatives further encompass PH10, another quick-acting neuroactive nasal spray, which is in preparation for Phase 2B clinical assessment as a standalone therapy for major depressive disorder (MDD). Additionally, VistaGen is developing AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is being investigated in conjunction with oral probenecid for its potential application in treating levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. VistaGen has established various collaborations, including a contract research and development agreement with Cato Research Ltd., a licensing agreement with Pherin Pharmaceuticals, Inc., and a license and collaboration agreement with EverInsight Therapeutics Inc. Founded in 1998, VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.

Preço para VTGN	Ativo B	Capitalização de mercado de B	Resultados
$123,040 $11.62M	NVDA	$5.460T	+46,979,716.61%
$101,167 $11.62M	AAPL	$4.489T	+38,628,057.12%
$93,311.87 $11.62M	GOOG	$4.141T	+35,628,715.01%
$80,414.22 $11.62M	MSFT	$3.569T	+30,704,070.07%
$63,051.48 $11.62M	AMZN	$2.798T	+24,074,540.22%

Preço para VTGN

Ativo B

Capitalização de mercado de B

Resultados

$123,040 $11.62M